Cancer inhibiting agent, antibody production enhancing agent, and therapeutic agent for hepatitis
US9339537B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 2, 2011 |
| Grant date | May 17, 2016 |
| Priority date | — |
| Expiry date | Mar 3, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2730/10134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are an agent for inhibition of cancer development, an agent for improvement of antibody productivity, and an agent for treatment of hepatitis. The agents have been completed by finding that cancer development is inhibited in a healthy subject by administering NK cells, and antibody productivity is improved by administering NK cells and a vaccine to a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.